# A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy Volunteers

> **NCT06951880** · PHASE1 · NOT_YET_RECRUITING · sponsor: **AstraZeneca** · enrollment: 178 (estimated)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** AZD4916
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06951880
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-27
- **Primary completion:** 2026-09-24
- **Final completion:** 2026-09-24
- **Target enrollment:** 178 (ESTIMATED)
- **Last updated:** 2025-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06951880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06951880, "A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06951880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*